018305636

CResponse

---

September 9, 2020

Trademark Summary

The trademark application cResponse was filed by CURESPONSE LTD., a corporation established under the laws of the State of Israel (the "Applicant"). The application was published for oppositions on October 13, 2020, and it was registered by office on January 20, 2021 without any oppositions.

The application was filed in English (Spanish was selected as the second language).

Change of name and professional address of the trademark registration was recorded on January 14, 2024. Change of name and professional address of the trademark registration was recorded on January 15, 2024.

---

Goods And Services

• The mark was filed in class 5 with following description of goods:
  
  1. Diagnostic testing materials for medical purposes
  2. Medical diagnostic reagents and assays for testing of tissue cultures and biological cultures
  3. Medical diagnostic reagents and assays for testing of body fluids
  4. Diagnostic test reagents for medical use
  5. Biological preparations for diagnostic purposes
  6. Diagnostic agents for medical and pharmaceutical purposes
  7. Diagnostic substances for medical purposes
  8. Medical diagnostic test strips
  9. Diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes
  10. Diagnostic biomarker reagents for medical purposes
  11. Diagnostic preparations for medical laboratory use
  12. In vitro diagnostic preparations for medical use
  13. Assay samples for medical and pharmaceutical use
  14. Biological tissue cultures for medical purposes.
• The mark was filed in class 42 with following description of goods:
  
  1. Tissue testing services for the diagnosis of cancer, and adjusting treatments
  2. Computer aided diagnostic testing services
  3. Laboratory testing
  4. Medical laboratory services
  5. Scientific research for medical purposes in the area of cancerous diseases
  6. Pharmaceutical product evaluation
  7. Testing services providing information for diagnosis, prognosis and predictive behavior of cancer
  8. Optimization of pharmaceutical treatment for cancer patients.
• The mark was filed in class 44 with following description of goods:
  
  1. Medical testing for diagnostic or treatment purposes
  2. Medical testing services relating to the diagnosis and treatment of diseases
  3. Medical testing services relating to optimization of pharmaceutical treatment for cancer patients
  4. Provision of information in the field of cancer screening, diagnosis and treatment
  5. Health care services for treating cancer.